ALKemist Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.33M

  • Investors
  • 7

ALKemist Bio General Information

Description

Developer of cellular immunotherapies designed to target ALK-positive cancer cells through engineered T-cell receptors. The company's platform utilizes a process that extracts, modifies and reinfuses T cells from patients, enabling individuals to get effective treatment with specific oncogene-driven malignancies and aiming to improve patient outcomes in oncology.

Contact Information

Website
www.alkemistbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Ettore De Sonnaz, 19
  • Piedmont
  • 10121 Turin
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Via Ettore De Sonnaz, 19
  • Piedmont
  • 10121 Turin
  • Italy

ALKemist Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ALKemist Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 03-Jun-2025 $3.33M Completed Pre-Clinical Trials
1. Seed Round 19-Feb-2024 Completed Pre-Clinical Trials
To view ALKemist Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ALKemist Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cellular immunotherapies designed to target ALK-positive cancer cells through engineered T-cell receptors.
Drug Discovery
Turin, Italy
5 As of 2026

South San Francisco, CA
 

Miami, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ALKemist Bio Competitors (52)

One of ALKemist Bio’s 52 competitors is RAPT Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RAPT Therapeutics Formerly VC-backed South San Francisco, CA
Xcovery Venture Capital-Backed Miami, FL
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 52 competitors. Get the full list »

ALKemist Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ALKemist Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
B-Engine Venture Capital Minority
Claris Ventures Venture Capital Minority
Club degli investitori Angel Group Minority
Ersel Banca Privata Holding Company Minority
Italian Angels for Growth Angel Group Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

ALKemist Bio FAQs

  • When was ALKemist Bio founded?

    ALKemist Bio was founded in 2023.

  • Where is ALKemist Bio headquartered?

    ALKemist Bio is headquartered in Turin, Italy.

  • What is the size of ALKemist Bio?

    ALKemist Bio has 5 total employees.

  • What industry is ALKemist Bio in?

    ALKemist Bio’s primary industry is Drug Discovery.

  • Is ALKemist Bio a private or public company?

    ALKemist Bio is a Private company.

  • What is the current valuation of ALKemist Bio?

    The current valuation of ALKemist Bio is .

  • What is ALKemist Bio’s current revenue?

    The current revenue for ALKemist Bio is .

  • How much funding has ALKemist Bio raised over time?

    ALKemist Bio has raised $7.65M.

  • Who are ALKemist Bio’s investors?

    B-Engine, Claris Ventures, Club degli investitori, Ersel Banca Privata, and Italian Angels for Growth are 5 of 7 investors who have invested in ALKemist Bio.

  • Who are ALKemist Bio’s competitors?

    RAPT Therapeutics, Xcovery, Adaptimmune Therapeutics, Repertoire Immune Medicines, and Allogene Therapeutics are some of the 52 competitors of ALKemist Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process